Visual evoked potentials and pulse wave velocity in inflammatory bowel disease

Turkish Journal of Gastroenterology

Volumn 26, Issue 1, 2015, Pages 15-19

  Aytaç, Erman ^a   Büyüktaş, Deram ^a   Baysal, Birol ^a   Atar, Murat ^a   Yildiz, Mustafa ^a,b   Baca, Bilgi ^a   Karahasanoʇlu, Tayfun ^a   Çelik, Aykut ^a   Seymen, Hakki Oktay ^a   Hamzaoʇlu, Ismail ^a  

^a ISTANBUL UNIVERSITY   (Turkey)

^b MINISTRY OF HEALTH   (Turkey)

Author keywords

Arterial stifness; Crohn's disease; Inflammatory bowel disease; Pulse wave velocity; Ulcerative colitis; Visual evoked potentials

Indexed keywords

ALBUMIN; CHOLESTEROL; HEMOGLOBIN; PROTEIN; TRIACYLGLYCEROL;

ADULT; AORTA; ARTICLE; CARDIOVASCULAR DIAGNOSTIC DEVICE; CARDIOVASCULAR FUNCTION; CHOLESTEROL BLOOD LEVEL; COMMON CAROTID ARTERY; COMPLIOR COLSON DEVICE; CONTROLLED STUDY; CROHN DISEASE; EVOKED VISUAL RESPONSE; FEMALE; FEMORAL ARTERY; HEMATOCRIT; HUMAN; LATENT PERIOD; MAJOR CLINICAL STUDY; MALE; MEAN ARTERIAL PRESSURE; PULSE WAVE; ULCERATIVE COLITIS; ULTRASOUND STRAIN GAUGE PRESSURE SENSITIVE TRANSDUCER; ULTRASOUND TRANSDUCER; VISION; VISUAL NEURONAL FUNCTION; BLOOD PRESSURE; CASE CONTROL STUDY; ECHOGRAPHY; MIDDLE AGED; PATHOPHYSIOLOGY; PHYSIOLOGY; PRESSURE TRANSDUCER; PROSPECTIVE STUDY;

ADULT; BLOOD PRESSURE; CAROTID ARTERY, COMMON; CASE-CONTROL STUDIES; COLITIS, ULCERATIVE; CROHN DISEASE; EVOKED POTENTIALS, VISUAL; FEMALE; FEMORAL ARTERY; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; PULSE WAVE ANALYSIS; TRANSDUCERS, PRESSURE;

EID: 84922551961     PISSN: 13004948     EISSN: None     Source Type: Journal    
DOI: 10.5152/tjg.2015.4349     Document Type: Article

References (38)

1. Rothfuss KS, Stange EF, Herrlinger KR. Extraintestinal manifestations and complications in inflammatory bowel diseases. World J Gastroenterol 2006; 14: 4819-31.
2. Seymen P, Selamet U, Aytac E., Trabulus S, Seymen HO. Evaluation of visual evoked potentials in chronic renal failure patients with different treatment modalities. J. Nephrol 2010; 23: 705-10.
3. Yildiz M, Masatlioglu S, Seymen P., Aytac E, Sahin B, Seymen HO. The carotid-femoral (aortic) pulse wave velocity as a marker of arterial stiffness in familial Mediterranean fever. Can J Cardiol 2006; 22: 1127-31.
4. Druschky A, Heckmann JG, Druschky K, Huk W.J., Erbguth F., Neundörfer B. Severe neurological complications of ulcerative colitis. J Clin Neurosci 2002; 9: 84-6.
5. Keene DL, Matzinger MA, Jacob P.J., Humphreys P. Cerebral vascular events associated with ulcerative colitis in children. Pediatr Neurol 2001; 24: 238-43.
6. Yilmaz S, Aydemir E, Maden A., Unsal B. The prevalence of ocular involvement in patients with inflammatory bowel disease. Int J Colorectal Dis 2007; 22: 1027-30.
7. Hayton SM, Kriss A, Wade A., Muller D P. The effects of different levels of allrac- and RRR-a-tocopheryl acetate (vitamin E) on visual function in rats. Clin Neurophysiol 2003; 114: 2124-31.
8. Seo M, Okada M, Yao T., Ueki M, Arima S, Okumura M. An index of disease activity in patients with ulcerative colitis. Am J Gastroenterol 1992; 87: 971-6.
9. Best WR, Becktel JM, Singleton J.W., Kern F Jr. Development of a Crohn's disease activity index. National Cooperative Crohn's Disease Study. Gastroenterology 1976; 70: 439-44.
10. Asmar R, Benetos A, Topouchian J., et al. Assessment of arterial distensibility by automatic pulse wave velocity measurement. Validation and clinical application studies. Hypertension 1995; 26: 485-90.
11. Odom JV, Bach M, Barber C., et al. Visual evoked potentials standard. Doc Ophthalmol 2004; 108: 115-23.
12. Otto D, Hudnell K, Boyes W., Janssen R, Dyer R. Electrophysiological measures of visual and auditory function as indices of neuro-toxicity. Toxicology 1988; 49: 205-18.
13. Otto DA, Hudnell HK. The use of visual and chemosensory evoked potentials in environmental and occupational health. Environ Res 1993; 62: 159-71.
14. Turker H, Terzi M, Bayrak O., Cengiz N, Onar M, Us O. Visual evoked potentials in differential diagnosis of multiple sclerosis and neu-robehcet's disease. Tohoku J Exp Med 2008; 216: 109-16.
15. Karlinger K, Györke T, Makö E, Mester A, Tarján Z. The epidemiology and the pathogenesis of inflammatory bowel disease. Eur J Radiol 2000; 35: 154-67.
16. Mintz R, Feller ER, Bahr R.L., Shah SA. Ocular manifestations of in-flammatory bowel disease. Inflamm Bowel Dis 2004; 10: 135-9.
17. Villain MA, Pageaux G P, Veyrac M, Arnaud B., Harris A, Greenfield DS. Effect of acetazolamide on ocular hemodynamics in pseudotumor cerebri associated with inflammatory bowel disease. Am J Ophthalmol 2002; 134: 778-80.
18. Rouleau J, Longmuir R, Lee AG. Optic disc edema with adjacent cilioretinal artery occlusion in a male with ulcerative colitis. Semin Ophthalmol 2007; 22: 25-8.
19. Anlar O, Akdeniz N, Tombul T., Calka O, Bilgili SG. Visual evoked potential findings in Behcet's disease without neurological manifestations. Int J Neurosci 2006; 116: 281-7.
20. Munro JM, Cotran RS. The pathogenesis of atherosclerosis: Atherogenesis and inflammation. Lab Invest 1988; 58: 249-61.
21. Cohn JN. Arterial compliance to stratify cardiovascular risk: More precision in therapeutic decision making. Am J Hypertens 2001; 14: 258-63.
22. Imura T, Yamamoto K, Kanamori K., Mikami T, Yasuda H. Non invasive ultrasonic measurement of the elastic properties of the human abdominal aorta. Cardiovasc Res 1986; 20: 208-14.
23. Roman MJ, Devereux RB, Schwartz J.E., et al. Arterial stiffness in chronic inflammatory diseases. Hypertension 2005; 46: 194-9.
24. Rachapalli SM. Inflammatory bowel diseases and atherosclerosis: do we need more studies? Inflamm Bowel Dis 2005; 11: 705.
25. Maharshak N, Arbel Y, Bornstein N.M., et al. Inflammatory bowel disease is not associated with increased intimal media thickening. Am J Gastroenterol 2007; 102: 1050-5.
26. Dorn SD, Sandler RS. Inflammatory bowel disease is not a risk factor for cardiovascular disease mortality: results from a systematic review and meta-analysis. Am J Gastroenterol 2007; 102: 662-7.
27. Dagli N, Poyrazoglu OK, Dagli A.F., et al. Is inflammatory bowel disease a risk factor for early atherosclerosis? Angiology 2010; 61: 198-204.
28. Papa A, Santoliquido A, Danese S., et al. Increased carotid intima-media thickness in patients with inflammatory bowel disease. Aliment Pharmacol Ther 2005; 22: 839-46.
29. Sappati Biyyani RS, Fahmy NM, Baum E, Nelson K.M., King JF. Inflammatory bowel disease and coronary artery disease. Indian J Gastroenterol 2009; 28: 28-30.
30. Selzer F, Sutton-Tyrrell K, Fitzgerald S.G., et al. Comparison of risk factors for vascular disease in the carotid artery and aorta in women with systemic lupus erythematosus. Arthritis Rheum 2004; 50: 151-9.
31. Van Doornum S, McColl G, Wicks I P. Accelerated atherosclerosis. An extraarticular feature of rheumatoid arthritis? Arthritis Rheum 2002; 46: 862-73.
32. Hatoum OA, Binion DG, Otterson M.F., Gutterman DD. Acquired microvascular dysfunction in inflammatory bowel disease: loss of nitric oxide-mediated vasodilation. Gastroenterology 2003; 125: 58-69.
33. Di Fabio F, Obrand D, Satin R., Gordon PH. Intraabdominal venous and arterial thromboembolism in inflammatory bowel disease. Dis Colon Rectum 2009; 52: 336-42.
34. De Bleecker JL, Leroy B P, Meire VI. Reversible visual deficit and Corpus callosum lesions due to metronidazole toxicity. Eur Neurol 2005; 53: 93-5.
35. Jarand J, Zochodne DW, Martin L.O., Voll C. Neurological complications of infliximab. J Rheumatol 2006; 33: 1018-20.
36. Oustamanolakis P, Koutroubakis IE, Messaritakis I, Kefalogiannis G., Niniraki M, Kouroumalis EA. Measurement of reticulocyte and red blood cell indices in the evaluation of anemia in inflammatory bowel disease. J Crohns Colitis 2011; 5: 295-300.
37. Hare GM, Tsui AK, McLaren A.T., Ragoonanan TE, Yu J, Mazer CD. Anemia and cerebral outcomes: many questions, fewer answers. Anesth Analg 2008; 107: 1356-70.
38. Simsek H, Gunes Y, Demir C., Sahin M, Gumrukcuoglu HA, Tuncer M. The effects of iron deficiency anemia on p wave duration and dispersion. Clinics (Sao Paulo) 2010; 65: 1067-71.